US Patent Issued to Midas Pharma on Sept. 15 for "Losartan-containing micro tablet for pediatric applications" (German Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,131, issued on Sept. 15, was assigned to Midas Pharma GmbH (Ingelheim, Germany).

"Losartan-containing micro tablet for pediatric applications" was invented by Joerg Breitkreutz (Haltern am See, Germany) and Valentine Lura (Teningen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to mini tablets for pediatric applications containing losartan or one of its pharmaceutically acceptable salts."

The patent was filed on May 9, 2022, under Application No. 18/559,440.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2F...